BiomX (PHGE) Interest Expenses (2018 - 2026)
BiomX (PHGE) posted Interest Expenses of $192000.0 for Q1 2026, up 3740.0% sequentially from $5000.0 in Q4 2025, and up 1645.45% YoY from $11000.0 in Q1 2025.
BiomX (PHGE) Interest Expenses (2018 - 2026) Analysis & Trends
BiomX has reported Interest Expenses for 9 years, with the latest figure at $192000.0 in Q1 2026.
- Quarterly Interest Expenses rose 1645.45% year-over-year to $192000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $862000.0 (up 7736.36% YoY) and the FY2025 annual result came in at $1.8 million, up 18.33% from the prior year.
- Interest Expenses advanced to $192000.0 in Q1 2026 per PHGE's latest filing, from $5000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $983000.0 in Q1 2022 and troughed at $5000.0 in Q4 2025.
- A 5-year average of $337187.5 and a median of $340000.0 in 2022 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2025 and 2026: Interest Expenses plunged 98.42% in 2025, then soared 1645.45% in 2026.
- Over 5 years, Interest Expenses stood at $50000.0 in 2022, then surged by 940.0% to $520000.0 in 2023, then tumbled by 81.54% to $96000.0 in 2024, then plunged by 94.79% to $5000.0 in 2025, then surged by 3740.0% to $192000.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $192000.0, $5000.0, and $11000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - | 192,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 192,000.00 |
| Mar 31, 2026 | 192,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 569,000.00 |
| Jun 30, 2024 | 569,000.00 |
| Dec 31, 2023 | 520,000.00 |
| Dec 31, 2023 | 520,000.00 |
| Sep 30, 2023 | 574,000.00 |
| Sep 30, 2023 | 574,000.00 |